Brief: Hanx Biopharmaceuticals (Wuhan)Enters Agreement To Establish Joint Ai-Driven Drug Discovery Lab
07/07/2026 15:18
BRIEF-Hanx Biopharmaceuticals (Wuhan)Enters Agreement To Establish Joint Ai-Driven Drug Discovery Lab July 7 (Reuters) - Hanx Biopharmaceuticals (Wuhan) Co Ltd 3378.HK:
ENTERS AGREEMENT TO ESTABLISH JOINT AI-DRIVEN DRUG DISCOVERY LAB
COLLABORATES WITH HUST-CITYU MACAU INSTITUTE ADVANCED INTERDISCIPLINARY RESEARCH CENTRE
Further company coverage: 3378.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hanx Biopharmaceuticals (Wuhan)
See all newsBrief: Hanx Biopharmaceuticals (Wuhan) Enters Agreement To Explore AI For Science In Drug Research
Brief: Hanx Biopharmaceuticals (Wuhan)Enters Agreement To Establish Joint Ai-Driven Drug Discovery Lab
Brief: Hanx Biopharmaceuticals (Wuhan) And Twinedge Bioscience Initiates Research Collaboration
Farmers in biggest cocoa producer are very short of fertilizer, survey says
Brief: Hanx Biopharmaceuticals (Wuhan) Says Xiao Jieyu Re-Designated As Executive Director